Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate

World Journal of Gastroenterology

Volumn 14, Issue 6, 2008, Pages 892-898

  Phongkitkarun, Sith ^a   Phaisanphrukkun, Cholada ^a   Jatchavala, Janjira ^a   Sirachainan, Ekaphop ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Computed tomography; Gastrointestinal stromal tumor; Imatinib mesylate

Indexed keywords

IMATINIB; IOPROMIDE; MEGLUMINE DIATRIZOATE; NONIONIC CONTRAST MEDIUM; OMMIPAQUE 300; UNCLASSIFIED DRUG; XENETRIX 300;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATIONAL STUDY; CYST; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR VOLUME;

EID: 40149107435     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.892     Document Type: Article

References (30)